Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Muscles can make their own androgens, which may help muscle growth.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

A rare ovarian tumor caused high male hormone levels, but surgery fixed it.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.